Saint Xiang Biology: Intends to jointly invest in Hasu Micro with related parties.

On March 15, Shengxiang Biology announced that the company plans to jointly invest in the establishment of Hunan Shengweihua Si Biological Technology Co., Ltd. with an affiliate, Hunan Jinfurong Shengxiang Biological Equity Investment Fund Partnership Enterprise, and use it as the investment entity for acquiring 100% equity of Huasiwu Microbial Technology (Shenzhen) Co., Ltd. After the transaction is completed, Shengweihua Si and Huasiwu Microbial will be included in the company's consolidated financial statements. Huasiwu Microbial is an enterprise that develops, produces, and sells in vitro diagnostic reagents and supporting instruments for human and animal use based on its proprietary infrared fluorescence enhancement technology. The company will invest a total of 65.438 million yuan in the project.